Male fertility restoration: In vivo and In vitro stem cell-based strategies using cryopreserved testis tissue - A scoping review

Research output: Contribution to journalReviewResearchpeer-review

Standard

Male fertility restoration : In vivo and In vitro stem cell-based strategies using cryopreserved testis tissue - A scoping review. / von Rohden, Elena; Jensen, Christian Fuglesang S; Andersen, Claus Yding; Sønksen, Jens; Fedder, Jens; Thorup, Jørgen; Ohl, Dana A; Fode, Mikkel; Hoffmann, Eva R; Mamsen, Linn Salto.

In: Fertility and Sterility, 09.07.2024.

Research output: Contribution to journalReviewResearchpeer-review

Harvard

von Rohden, E, Jensen, CFS, Andersen, CY, Sønksen, J, Fedder, J, Thorup, J, Ohl, DA, Fode, M, Hoffmann, ER & Mamsen, LS 2024, 'Male fertility restoration: In vivo and In vitro stem cell-based strategies using cryopreserved testis tissue - A scoping review', Fertility and Sterility. https://doi.org/10.1016/j.fertnstert.2024.07.010

APA

von Rohden, E., Jensen, C. F. S., Andersen, C. Y., Sønksen, J., Fedder, J., Thorup, J., Ohl, D. A., Fode, M., Hoffmann, E. R., & Mamsen, L. S. (2024). Male fertility restoration: In vivo and In vitro stem cell-based strategies using cryopreserved testis tissue - A scoping review. Fertility and Sterility. https://doi.org/10.1016/j.fertnstert.2024.07.010

Vancouver

von Rohden E, Jensen CFS, Andersen CY, Sønksen J, Fedder J, Thorup J et al. Male fertility restoration: In vivo and In vitro stem cell-based strategies using cryopreserved testis tissue - A scoping review. Fertility and Sterility. 2024 Jul 9. https://doi.org/10.1016/j.fertnstert.2024.07.010

Author

von Rohden, Elena ; Jensen, Christian Fuglesang S ; Andersen, Claus Yding ; Sønksen, Jens ; Fedder, Jens ; Thorup, Jørgen ; Ohl, Dana A ; Fode, Mikkel ; Hoffmann, Eva R ; Mamsen, Linn Salto. / Male fertility restoration : In vivo and In vitro stem cell-based strategies using cryopreserved testis tissue - A scoping review. In: Fertility and Sterility. 2024.

Bibtex

@article{a2e8766de5ba48fc91e53f1cfa316491,
title = "Male fertility restoration: In vivo and In vitro stem cell-based strategies using cryopreserved testis tissue - A scoping review",
abstract = "IMPORTANCE: Advances in the treatment of childhood cancer have significantly improved survival rates, with more than 80% of survivors reaching adulthood. However, gonadotoxic cancer treatments endanger future fertility and prepubertal males have no option to preserve fertility by sperm cryopreservation. Also, boys with cryptorchidism are at risk of compromised fertility in adulthood.OBJECTIVE: This scoping review focuses on male fertility restoration, particularly relevant for prepubertal male cancer survivors and boys with cryptorchidism. The aim was to investigate current evidence for fertility restoration strategies, explore barriers to clinical implementation, and outline potential steps to overcome these barriers.EVIDENCE REVIEW: The review was conducted following the PRISMA-ScR criteria and previously published guidelines and examines studies using human testis tissue of prepubertal boys or healthy male adults. A literature search in PubMed was conducted and 72 relevant studies were identified, including in vivo and in vitro approaches.FINDINGS: In vivo strategies, such as testis tissue engraftment and spermatogonial stem cell (SSC) transplantation, hold promise for promoting cell survival and differentiation. Yet complete spermatogenesis has not been achieved. In vitro approaches focus on the generation of male germ cells from direct germ cell maturation in various culture systems, alongside human induced pluripotent stem cells (iPSCs) and embryonic stem cells (ESCs). These approaches mark significant advancements in understanding and promoting spermatogenesis but achieving fully functional spermatozoa in vitro remains a challenge. Barriers to clinical implementation include the risk of reintroducing malignant cells and introduction of epigenetic changes.CONCLUSION: Male fertility restoration is an area in rapid development. Based on the reviewed studies the most promising and advanced strategy for restoring male fertility using cryopreserved testis tissue is direct testis tissue transplantation.RELEVANCE: This review identifies persistent barriers to the clinical implementation of male fertility restoration. However, direct transplantation of frozen-thawed testis tissue remains a promising strategy that is on the verge of clinical application.",
author = "{von Rohden}, Elena and Jensen, {Christian Fuglesang S} and Andersen, {Claus Yding} and Jens S{\o}nksen and Jens Fedder and J{\o}rgen Thorup and Ohl, {Dana A} and Mikkel Fode and Hoffmann, {Eva R} and Mamsen, {Linn Salto}",
note = "Copyright {\textcopyright} 2024. Published by Elsevier Inc.",
year = "2024",
month = jul,
day = "9",
doi = "10.1016/j.fertnstert.2024.07.010",
language = "English",
journal = "Sexuality, Reproduction and Menopause",
issn = "1546-2501",
publisher = "Elsevier",

}

RIS

TY - JOUR

T1 - Male fertility restoration

T2 - In vivo and In vitro stem cell-based strategies using cryopreserved testis tissue - A scoping review

AU - von Rohden, Elena

AU - Jensen, Christian Fuglesang S

AU - Andersen, Claus Yding

AU - Sønksen, Jens

AU - Fedder, Jens

AU - Thorup, Jørgen

AU - Ohl, Dana A

AU - Fode, Mikkel

AU - Hoffmann, Eva R

AU - Mamsen, Linn Salto

N1 - Copyright © 2024. Published by Elsevier Inc.

PY - 2024/7/9

Y1 - 2024/7/9

N2 - IMPORTANCE: Advances in the treatment of childhood cancer have significantly improved survival rates, with more than 80% of survivors reaching adulthood. However, gonadotoxic cancer treatments endanger future fertility and prepubertal males have no option to preserve fertility by sperm cryopreservation. Also, boys with cryptorchidism are at risk of compromised fertility in adulthood.OBJECTIVE: This scoping review focuses on male fertility restoration, particularly relevant for prepubertal male cancer survivors and boys with cryptorchidism. The aim was to investigate current evidence for fertility restoration strategies, explore barriers to clinical implementation, and outline potential steps to overcome these barriers.EVIDENCE REVIEW: The review was conducted following the PRISMA-ScR criteria and previously published guidelines and examines studies using human testis tissue of prepubertal boys or healthy male adults. A literature search in PubMed was conducted and 72 relevant studies were identified, including in vivo and in vitro approaches.FINDINGS: In vivo strategies, such as testis tissue engraftment and spermatogonial stem cell (SSC) transplantation, hold promise for promoting cell survival and differentiation. Yet complete spermatogenesis has not been achieved. In vitro approaches focus on the generation of male germ cells from direct germ cell maturation in various culture systems, alongside human induced pluripotent stem cells (iPSCs) and embryonic stem cells (ESCs). These approaches mark significant advancements in understanding and promoting spermatogenesis but achieving fully functional spermatozoa in vitro remains a challenge. Barriers to clinical implementation include the risk of reintroducing malignant cells and introduction of epigenetic changes.CONCLUSION: Male fertility restoration is an area in rapid development. Based on the reviewed studies the most promising and advanced strategy for restoring male fertility using cryopreserved testis tissue is direct testis tissue transplantation.RELEVANCE: This review identifies persistent barriers to the clinical implementation of male fertility restoration. However, direct transplantation of frozen-thawed testis tissue remains a promising strategy that is on the verge of clinical application.

AB - IMPORTANCE: Advances in the treatment of childhood cancer have significantly improved survival rates, with more than 80% of survivors reaching adulthood. However, gonadotoxic cancer treatments endanger future fertility and prepubertal males have no option to preserve fertility by sperm cryopreservation. Also, boys with cryptorchidism are at risk of compromised fertility in adulthood.OBJECTIVE: This scoping review focuses on male fertility restoration, particularly relevant for prepubertal male cancer survivors and boys with cryptorchidism. The aim was to investigate current evidence for fertility restoration strategies, explore barriers to clinical implementation, and outline potential steps to overcome these barriers.EVIDENCE REVIEW: The review was conducted following the PRISMA-ScR criteria and previously published guidelines and examines studies using human testis tissue of prepubertal boys or healthy male adults. A literature search in PubMed was conducted and 72 relevant studies were identified, including in vivo and in vitro approaches.FINDINGS: In vivo strategies, such as testis tissue engraftment and spermatogonial stem cell (SSC) transplantation, hold promise for promoting cell survival and differentiation. Yet complete spermatogenesis has not been achieved. In vitro approaches focus on the generation of male germ cells from direct germ cell maturation in various culture systems, alongside human induced pluripotent stem cells (iPSCs) and embryonic stem cells (ESCs). These approaches mark significant advancements in understanding and promoting spermatogenesis but achieving fully functional spermatozoa in vitro remains a challenge. Barriers to clinical implementation include the risk of reintroducing malignant cells and introduction of epigenetic changes.CONCLUSION: Male fertility restoration is an area in rapid development. Based on the reviewed studies the most promising and advanced strategy for restoring male fertility using cryopreserved testis tissue is direct testis tissue transplantation.RELEVANCE: This review identifies persistent barriers to the clinical implementation of male fertility restoration. However, direct transplantation of frozen-thawed testis tissue remains a promising strategy that is on the verge of clinical application.

U2 - 10.1016/j.fertnstert.2024.07.010

DO - 10.1016/j.fertnstert.2024.07.010

M3 - Review

C2 - 38992744

JO - Sexuality, Reproduction and Menopause

JF - Sexuality, Reproduction and Menopause

SN - 1546-2501

ER -

ID: 398156338